Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta-protein”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT02669225
What this trial is testing

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Who this might be right for
Normal Physiology
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 22
Not applicableEnded earlyNCT00978536
What this trial is testing

A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).

Who this might be right for
Disseminated Sclerosis
Nantes University Hospital 29
Not applicableUnknownNCT01819545
What this trial is testing

The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 300
Not applicableStudy completedNCT01754168
What this trial is testing

Amyloid Beta and Cognition in Parkinson Disease

Who this might be right for
Parkinson DiseaseNeurological Disorders
University of Michigan 44
Not applicableStudy completedNCT01194713
What this trial is testing

Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics

Who this might be right for
Alzheimer Disease
University Medical Center Nijmegen 26
Early research (Phase 1)Study completedNCT01978548
What this trial is testing

Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 45
Not applicableUnknownNCT04350801
What this trial is testing

Home-based Cognitive Monitoring in MCI

Who this might be right for
Mild Cognitive Impairment
Asan Medical Center 40
Not applicableStudy completedNCT02959489
What this trial is testing

Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)

Who this might be right for
Alzheimer DiseaseAmyloid Beta-PeptidesRisk Assessment+3 more
Brigham and Women's Hospital 315
Testing effectiveness (Phase 2)Looking for participantsNCT04629547
What this trial is testing

Sleep Trial to Prevent Alzheimer's Disease

Who this might be right for
SleepAlzheimer Disease
University of Minnesota 120
Not applicableStudy completedNCT01189084
What this trial is testing

Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 14
Testing effectiveness (Phase 2)UnknownNCT04926272
What this trial is testing

Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
First Affiliated Hospital of Fujian Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00088387
What this trial is testing

Effect of Lithium and Divalproex in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute of Neurological Disorders and Stroke (NINDS) 35
Testing effectiveness (Phase 2)Study completedNCT01148498
What this trial is testing

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 55
Early research (Phase 1)Study completedNCT00965588
What this trial is testing

Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 19
Not applicableStudy completedNCT03077620
What this trial is testing

Sleep Quality and Amyloid-Beta Kinetics

Who this might be right for
Amyloid-beta
Washington University School of Medicine 48
Not applicableStudy completedNCT01982578
What this trial is testing

Genistein as a Possible Treatment for Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease
Fundación para la Investigación del Hospital Clínico de Valencia 27
Post-approval studies (Phase 4)Study completedNCT00046358
What this trial is testing

The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute of Mental Health (NIMH) 50
Post-approval studies (Phase 4)Study completedNCT02161458
What this trial is testing

Escitalopram Effects on CSF Amyloid Beta

Who this might be right for
Amyloid Beta Protein
University of Pennsylvania 98
Testing effectiveness (Phase 2)Study completedNCT03354143
What this trial is testing

Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

Who this might be right for
Hypertension
University of Texas Southwestern Medical Center 85
Not applicableStudy completedNCT07307872
What this trial is testing

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Neurodegenerative DiseaseDementia+1 more
Amoneta Diagnostics SAS 150
Next Page